Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002201 · ClinicalTrials.gov registry record · NA
A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients
A NA study, sponsored by Abbott.
- Completed
- Registry status
- NA
- Development phase
NCT00002201: Completed NA study, sponsored by Abbott.
NCT00002201 is a NA study that has completed, run by Abbott. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002201, a NA study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The purpose of this study is to see if it is safe and effective to give ritonavir plus nelfinavir to HIV-infected patients. This study will also see how ritonavir and nelfinavir are absorbed by the body and how they affect the level of HIV in the blood.
Interventions
- DRUG Ritonavir
- DRUG Nelfinavir mesylate
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002201 record still lists
NCT00002201 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Ritonavir is the first listed.
NCT00002201 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002201 about?
NCT00002201 is a clinical study titled "A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients". The purpose of this study is to see if it is safe and effective to give ritonavir plus nelfinavir to HIV-infected patients. This study will also see how ritonavir and nelfinavir are absorbed by the body and how they affect the level of HIV in the blood.
What is the current status of trial NCT00002201?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002201?
The interventions under investigation include: Ritonavir (DRUG), Nelfinavir mesylate (DRUG).
Who is sponsoring clinical trial NCT00002201?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.